Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
ConditionProstate Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorUniversity of Southern California
About this trial
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Eligibility criteria
Qualifiers
Men of all racial and ethnic groups 18 years of age or older
Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
Prior participation on clinical trials is allowed
Disqualifiers
Inability to give informed consent
Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
Trial design
Treatments tested in this trial
- Non-Interventional Study
Treatment groups
300 Participants
are divided into 1 treatment groupLocations
2Los Angeles General Medical Center90033, Los AngelesCalifornia, United States
USC / Norris Comprehensive Cancer Center90033, Los AngelesCalifornia, United States
Sponsors and collaborators
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov